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Abstract
Secretion of the a-subunit of pituitary glycoprotein hormones usually
follows the secretion of intact gonadotropins and is increased in
gonadal failure and decreased in isolated gonadotropin deficiency.
The aim of the present study was to determine the levels of the a-
subunit in the serum of patients with cirrhosis of the liver and to
compare the results obtained for eugonadal cirrhotic patients with
those obtained for cirrhotic patients with hypogonadotropic hypogo-
nadism. Forty-seven of 63 patients with cirrhosis (74.6%) presented
hypogonadism (which was central in 45 cases and primary in 2), 7
were eugonadal, and 9 women were in normal menopause. The serum
a-subunit was measured by the fluorimetric method using monoclonal
antibodies. Cross-reactivity with LH, TSH, FSH and hCG was 6.5,
1.2, 4.3 and 1.1%, respectively, with an intra-assay coefficient of
variation (CV) of less than 5% and an interassay CV of 5%, and
sensitivity limit of 4 ng/l. The serum a-subunit concentration ranged
from 36 to 6253 ng/l, with a median of 273 ng/l. The median was 251
ng/l for patients with central hypogonadism and 198 ng/l for eugonadal
patients. The correlation between the a-subunit and basal LH levels
was significant both in the total sample (r = 0.48, P<0.01) and in the
cirrhotic patients with central hypogonadism (r = 0.33, P = 0.02).
Among men with central hypogonadism there was a negative correla-
tion between a-subunit levels and total testosterone levels (r = -0.54,
P<0.01) as well as free testosterone levels (r = -0.53, P<0.01). In
conclusion, although the a-subunit levels are correlated with LH
levels, at present they cannot be used as markers for hypogonadism in
patients with cirrhosis of the liver.
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Introduction
The a-subunit of glycoprotein hormones,
usually detected in the serum of normal
individuals (1-3), has been used as a tumor
marker for gonadotropin- or TSH-secreting
pituitary adenomas (4), for GH-secreting
tumors (4,5) and for nonsecreting pituitary
tumors (3,4). The a-subunit is secreted in a
pulsatile manner by the thyrotropes and by
the gonadotropes (6), but especially by the
latter (7). Its production is stimulated by
TRH (7) and by GnRH (8) and is suppressed
with the use of thyroid hormone (9) or estra-
diol (1,10) in the absence of nonfunctioning
tumors. Regulation by GnRH is the most
important one, with 90% concordance be-
tween the pulses of the a-subunit and of LH
(11). This pulsatility decreases after block-
age of GnRH receptors induced by their
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antagonist (11) and is normalized in indi-
viduals with hypogonadotropic hypogo-
nadism treated with GnRH (12).
In nonphysiological situations, most of
the times the a-subunit oscillates according
to the respective intact heterodimeric hor-
mone, increasing in primary hypothyroidism
(9,13) and in primary gonadal failure (6,10),
and decreasing in hypogonadotropic hypogo-
nadism (14,15). Dissociation between the
secretion of the a-subunit and secretion of
the complete hormone may occasionally oc-
cur, as observed during the use of GnRH
agonists in men with glycoprotein hormone-
secreting pituitary tumors, when LH is sup-
pressed and high subunit levels are main-
tained (16). In patients with cirrhosis of the
liver, hypogonadism is a frequent finding
regardless of the etiology of the disease (17).
Most of the time, despite the generalized
advanced gonadal failure, gonadotropin lev-
els are low, indicating involvement of the
hypothalamus-pituitary axis. The site of this
disorder is the hypothalamus since these
patients do not present the usual LH pulsatility
(18), since exogenous GnRH stimulates LH
and FSH (19-21) and since the picture of
hormonal deficiency is reversed after liver
transplant (21-23). The secretory status of
the a-subunit has not been established in this
form of hypogonadism.
The aim of the present study was to deter-
mine the a-subunit levels in the serum of
patients with cirrhosis of the liver and to
compare the results obtained for hypogonadal
and non-hypogonadal patients.
Material and Methods
The sample consisted of 63 patients, 33
men and 30 women, average age 53 years
(range: 19 to 76 years), with a clinical and/or
histological diagnosis of cirrhosis of liver of
different etiologies such as alcohol (N = 13),
hepatitis C virus (N = 22), alcohol plus hepa-
titis C virus (N = 15), hepatitis B virus (N = 1),
hepatitis B and C viruses (N = 2), hepatitis C
virus plus sclerosing cholangitis (N = 1), pri-
mary biliary cirrhosis (N = 1), and cryptogen-
ic cirrhosis (N = 8). The clinical diagnosis
was based on a previous history or present
manifestations of cirrhosis, such as portal
hypertension, bleeding esophageal and gas-
tric varices, ascites, spontaneous bacterial
peritonitis, encephalopathy and coagulopa-
thy. In 37 cases the liver biopsy confirmed
hepatic cirrhosis. The severity of liver dam-
age was evaluated in terms of Child-Pugh
score, which takes into account the degree of
encephalopathy and ascites, the bilirubin and
albumin levels and the prothrombin time (24).
All patients were euthyroid, as determined by
TSH measurement. None of the patients was
using hormones or drugs which could alter
the gonadotropin levels.
Gonadal function was evaluated on the
basis of clinical and laboratory parameters.
Total (normal range = 2.8-9.8 ng/ml) and free
(normal range = 12.4-40.0 pg/ml) plasma tes-
tosterone were determined by RIA and estra-
diol (normal range for males = up to 40 and
for females = 30-150 pg/ml), LH (normal
range for males = 1.3-19.8 and for females =
0.7-35.2 mIU/ml) and FSH (normal range for
males = 2.0-12.8 and for females = 3.1-15.7
mIU/ml) were determined by chemilumines-
cence using commercial kits in our labora-
tory. The patients were divided into 4 groups:
group 1 consisted of eugonadal patients, group
2 of amenorrheic women older than 50 years
with increased basal gonadotropins (normal
menopause), and group 3 and group 4 con-
sisted of women in the fertile age with hy-
pogonadism, e.g., presenting amenorrhea or
absence of vaginal bleeding for at least 6
months and men with hypogonadism, e.g.,
presenting low levels of free testosterone.
Hypogonadism was considered to be primary
when one or both gonadotropins were in-
creased (group 3). Group 4 was composed of
patients with hypogonadism of central origin,
e.g., no increase in basal gonadotropins.
The free a-subunit was determined by
the fluorimetric method, using monoclonal
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antibodies. Cross-reactivity with LH, TSH,
FSH and hCG was 6.5, 1.2, 4.3 and 1.1%,
respectively, with an intra-assay coefficient
of variation (CV) of less than 5% and an
interassay CV of 5%, and sensitivity limit of
4 ng/l. The values considered normal for the
method range from 120 to 790 ng/l (median:
250) for men, from 88 to 604 ng/l (median:
291) for women, and from 341 to 4071 ng/l
(median 1856) for menopausal women (25).
For statistical analysis, the results are
reported as median, minimum and maxi-
mum values of distribution, with the excep-
tion of serum albumin levels which are re-
ported as means – SD. The nonparametric
Mann-Whitney or Kruskal-Wallis test was
used according to the number of groups evalu-
ated. The chi-square association test and the
Spearman correlation coefficient test were
calculated. The level of significance was
considered to be P<0.05.
This study was approved by the Ethics
Committee of the institution and informed
consent was obtained from the subjects.
Results
Hypogonadism was diagnosed in 47 indi-
viduals, with 45 cases being of central etiol-
ogy and 2 of primary etiology. Of the remain-
ing patients, 7 were eugonadal and 9 were
menopausal women. Total testosterone levels
ranged from 3.0 to 5.8 ng/ml for eugonadal
men and from 0.1 to 14.0 ng/ml for central
hypogonadal men, while free testosterone
ranged from 15 to 21 and from 0.3 to 13.0 pg/
ml for these same groups. Amongst men, 5
presented increased estradiol while among
women, 19 presented estradiol levels which
were lower than the minimum expected for
the follicular phase. The range of estradiol
values was 26.0 to 225 pg/ml in eugonadal
women, less than 10 to 95 pg/ml in meno-
pausal women and less than 10 to 75 pg/ml in
women with central hypogonadism. Regard-
ing gonadotropins, the median, minimum and
maximum values for LH were 3.9 (0.3-55.9),
34.5 (6.7-102.5) and 4.1 mIU/ml (0.1-20.4),
respectively, for eugonadal and menopausal
subjects and for subjects with central hypogo-
nadism. For FSH, these values were 4.3 (2.4-
14.0), 60.7 (26.8-129.0) and 5.5 (0.1-19.5)
mIU/ml. There was no significant difference
in LH or FSH levels between eugonadal and
central hypogonadal patients.
Mean serum albumin levels were 3.1 g/dl
(normal values = 3.5-5.5; range 2.0-4.5). The
severity of hepatic disease in each group,
according to the CHILD score, is presented in
Table 1; 22.9% of the patients were classified
as Child-Pugh A, 50.8% as Child-Pugh B and
27% as Child-Pugh C. The analysis of a pos-
sible correlation between gonadal function
and Child-Pugh score was significant, sug-
gesting a correlation between these variables.
The concentration of the a-subunit ranged
from 36 to 6253 ng/l (median: 273 ng/l). In
the two patients with primary hypogonadism,
the a-subunit levels were 1568 and 1005 ng/
l. The median and distribution of the a-
subunit levels for the remaining hypogonadal,
eugonadal and menopausal subjects are listed
in Table 2. No statistically significant differ-
ence in a-subunit levels was detected among
these groups. The a-subunit levels of pa-
tients with cirrhosis associated with alcohol
(N = 28, median 222.5 ng/l) were not statis-
tically different from the levels observed in
the patients with cirrhosis of other etiologies
(N = 35, median 313 ng/l).
The correlation between a-subunit and
basal LH levels was significant both for the
total sample (r = 0.48, P<0.01) and for cir-
rhotic patients with central hypogonadism (r
Table 1 – Severity of hepatic disease and gonadal function in the cirrhotic patients who
participated in the study.
Group N Child-Pugh A Child-Pugh B Child-Pugh C
Eugonadal 7 5 2 -
Menopausal 9 3 6 -
Primary hypogonadism 2 - 1 1
Central hypogonadism 45 6 23 16
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= 0.33, P = 0.02). A significant negative
correlation between a-subunit levels and to-
tal testosterone (r = -0.54, P<0.01) and free
testosterone (r = -0.53, P<0.01) was ob-
served in men with central hypogonadism.
No association was observed between a-
subunit levels or serum albumin levels and
severity of hepatic disease according to the
Child-Pugh score.
Discussion
The high prevalence of hypogonadism of
central etiology in the population of cirrhotic
patients evaluated here is related to the se-
verity of liver disease, which triggers a hypo-
thalamic disorder secondary to an adverse
environment (21). This diagnosis, however,
does not invalidate the presence of gonadal
lesion in some patients from this group.
The production of the a-subunit is paral-
lel to LH secretion during the different phases
of life, increasing from prepuberty to adoles-
cence (26). Thus, our finding of a positive
correlation between a-subunit levels and LH
levels agrees with data reported elsewhere
(6,12,26). On the other hand, no statistically
significant difference in a-subunit levels was
detected between patients with central hy-
pogonadism, eugonadism and menopausal
women. Classically, a-subunit levels are el-
evated in menopause (1-3,13), a fact that
was observed here only as a tendency. Our
findings are probably related to the small
sample of menopausal women studied (9
patients), since their gonadotropin levels were
as expected.
Studies on gonadotropin deficiency alone
in hypogonadotropic hypogonadism have
reported low a-subunit values (12,14). Spratt
and colleagues (12) studying 6 hypogonadal
men with normal endogenous TSH secretion
detected circulating a-subunit levels close
to or below assay detection limits. Winters
and Troen (14) studying 4 hypogonadal men
observed low but usually detectable levels of
a-subunit. Several possibilities may justify
the absence of this finding among the
hypogonadal patients in the present series.
The first is that our sample is not homoge-
neous in terms of number of patients in each
group and that there is dispersion of the
results for hypogonadal patients, two of
whom had the highest a-subunit value in the
sample, including menopausal women. The
second possibility is that, although a hypo-
thalamic disorder exists both in gonadotro-
pin deficiency alone and in hypogonadism
associated with cirrhosis, the basic mecha-
nism of the diseases is different: in the first
condition endogenous GnRH secretion is
undetectable, whereas in the second GnRH
deficiency is transitory. This factor may be a
determinant of the differential behavior of
the a-subunit. Another explanation is that in
hypogonadism associated with cirrhosis,
basal LH levels are higher than those ob-
served in individuals with gonadotropin de-
ficiency alone, a possibility that was not
investigated here. The possibilities of alter-
ation in the hepatic clearance of the a-sub-
unit or of a toxic factor associated with
cirrhosis which may interfere with the pitu-
itary gland dynamics should also be consid-
ered.
Also important was our finding of a nega-
tive correlation between the levels of a-
subunit and testosterone, contrary to what
would be expected for central hypogonadism.
In conclusion, it seems clear that there is
a parallelism between hepatic and gonadal
dysfunction, and that in hypogonadism sec-
ondary to cirrhosis of liver, a-subunit levels
are correlated with LH levels but cannot be
used as an additional diagnostic criterion of
hypogonadism in these patients.
Table 2 – Serum a-subunit concentrations of cirrhotic patients.
Group N Median (ng/l) Distribution (ng/l)
Eugonadal 7 198 41-699
Menopausal 9 549 163-3778
Central hypogonadism 45 251 36-6253
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